Cognex Corporation (NASDAQ:CGNX) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Shares of Cognex Corporation (NASDAQ:CGNX - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the sixteen brokerages that are presently covering the firm, Marketbeat.com reports. Four equities research analysts have rated the stock with a hold recommendation, ten have assigned a buy recommendation and two have issued a strong buy recommendation on the company. The average 1-year price target among analysts that have updated their coverage on the stock in the last year is $72.3077.

Several research analysts recently weighed in on CGNX shares. Needham & Company LLC lifted their price target on Cognex from $67.00 to $75.00 and gave the company a "buy" rating in a research report on Friday, May 8th. The Goldman Sachs Group reaffirmed a "buy" rating and issued a $80.00 target price (up from $70.00) on shares of Cognex in a research note on Monday, May 11th. Sanford C. Bernstein reaffirmed an "outperform" rating and set a $75.00 target price on shares of Cognex in a research note on Thursday, May 7th. Weiss Ratings reissued a "hold (c)" rating on shares of Cognex in a research note on Friday, May 15th. Finally, Wall Street Zen upgraded Cognex from a "hold" rating to a "buy" rating in a research report on Saturday, May 9th.

Insider Activity

In other news, VP Darren Marc Long sold 20,252 shares of the stock in a transaction dated Wednesday, May 27th. The stock was sold at an average price of $66.34, for a total value of $1,343,517.68. Following the transaction, the vice president owned 3,990 shares in the company, valued at approximately $264,696.60. This represents a 83.54% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, VP Laura Ann Macdonald sold 41,600 shares of the firm's stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $65.56, for a total value of $2,727,296.00. Following the sale, the vice president directly owned 5,258 shares in the company, valued at $344,714.48. This trade represents a 88.78% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders have sold 224,847 shares of company stock worth $14,975,098. Corporate insiders own 1.70% of the company's stock.

Institutional Trading of Cognex

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Northwestern Mutual Wealth Management Co. lifted its holdings in shares of Cognex by 173,138.2% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 10,477,448 shares of the scientific and technical instruments company's stock valued at $376,979,000 after purchasing an additional 10,471,400 shares during the last quarter. Pictet Asset Management Holding SA lifted its stake in Cognex by 27.9% in the fourth quarter. Pictet Asset Management Holding SA now owns 7,013,184 shares of the scientific and technical instruments company's stock valued at $252,360,000 after buying an additional 1,529,010 shares during the last quarter. Price T Rowe Associates Inc. MD boosted its holdings in shares of Cognex by 31.0% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 5,314,896 shares of the scientific and technical instruments company's stock valued at $191,231,000 after acquiring an additional 1,258,629 shares during the period. Disciplined Growth Investors Inc. MN grew its position in shares of Cognex by 0.9% during the second quarter. Disciplined Growth Investors Inc. MN now owns 4,768,716 shares of the scientific and technical instruments company's stock worth $151,264,000 after acquiring an additional 40,927 shares during the last quarter. Finally, Geode Capital Management LLC grew its position in shares of Cognex by 27.1% during the fourth quarter. Geode Capital Management LLC now owns 3,950,299 shares of the scientific and technical instruments company's stock worth $142,154,000 after acquiring an additional 842,783 shares during the last quarter. Institutional investors and hedge funds own 88.12% of the company's stock.

Cognex Trading Down 4.7%

Shares of CGNX opened at $67.38 on Friday. The business's 50 day moving average is $64.99 and its 200 day moving average is $57.09. Cognex has a 12-month low of $34.60 and a 12-month high of $72.88. The company has a market capitalization of $11.21 billion, a PE ratio of 65.42 and a beta of 1.49.

Cognex (NASDAQ:CGNX - Get Free Report) last released its quarterly earnings results on Wednesday, August 5th. The scientific and technical instruments company reported $0.45 earnings per share for the quarter, beating the consensus estimate of $0.42 by $0.03. Cognex had a return on equity of 13.82% and a net margin of 16.05%.The company had revenue of $291.26 million for the quarter, compared to analyst estimates of $292.10 million. During the same quarter in the prior year, the firm posted $0.25 EPS. Cognex's quarterly revenue was up 16.9% compared to the same quarter last year. Cognex has set its FY 2026 guidance at 1.640-1.680 EPS and its Q3 2026 guidance at 0.500-0.540 EPS. Equities research analysts predict that Cognex will post 1.48 earnings per share for the current year.

Cognex Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, September 3rd. Shareholders of record on Thursday, August 20th will be issued a dividend of $0.085 per share. The ex-dividend date is Thursday, August 20th. This represents a $0.34 dividend on an annualized basis and a yield of 0.5%. Cognex's dividend payout ratio is 40.48%.

Key Stories Impacting Cognex

Here are the key news stories impacting Cognex this week:

• Positive Sentiment: Second-quarter adjusted EPS was $0.45, above the $0.42 analyst consensus and up from $0.25 a year earlier. Revenue reached a record $291.3 million, rising 16.9% year over year, while net income increased sharply. Margin improvement, favorable product mix, and cost controls supported the earnings beat. Cognex Q2 Earnings Beat on Margin Gains Despite Revenue Miss
• Positive Sentiment: Cognex raised its outlook. Third-quarter revenue guidance of $300 million to $320 million and EPS guidance of $0.50 to $0.54 are well above consensus estimates of $279.2 million and $0.37, respectively. Full-year 2026 EPS guidance was raised to $1.64-$1.68, versus the prior analyst estimate of $1.48, with revenue projected at $1.13-$1.15 billion. Cognex Corporation 2026 Q2 Results Earnings Call Presentation
• Positive Sentiment: The company declared a quarterly dividend of $0.085 per share, payable September 3 to shareholders of record August 20. The payout provides a modest shareholder return, although the reported yield is approximately 0.5%. Cognex Delivers Record Q2 Results and Raises Dividend
• Neutral Sentiment: Management attributed growth to broad-based strength across most major end markets, which supports the recovery outlook for Cognex’s industrial machine-vision business. However, investors will look for this momentum to translate into sustained revenue growth.
• Negative Sentiment: Quarterly revenue narrowly missed the $292.1 million consensus estimate. For a stock trading at a relatively high earnings multiple, even a small top-line miss may outweigh the EPS beat and strong forward guidance. Cognex Misses Q2 CY2026 Revenue Estimates
• Negative Sentiment: Reported insider activity showed company insiders selling shares without recorded purchases during the past six months. While such sales may reflect routine diversification, they can add to investor caution following the earnings release.

Cognex Company Profile

Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.

The company's product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source